Inventor · disambiguated record
Lijun Wu
Also filed as: WU LIJUN
30 granted patents·17 pending applications·362 citations·filing 1997–2025
96Inventor score
Files withPROMAB BIOTECHNOLOGIES INC18CARIBOU BIOSCIENCES INC9MILLENNIUM PHARM INC7Peking Union Medical College Hospital3BEIJING DAJIA INTERNET INFORMATION TECH CO LTD2
Top patents by PatentIndex Score
47 records- 0194US11142583B2BCMA-CAR-natural killer (NK) cells and methods related theretoCARIBOU BIOSCIENCES INC·Filed 2021·Granted Oct 12, 2021·2 cites·16 claims
- 0293US11472884B2Humanized BCMA antibody and BCMA-CAR-T cellsCARIBOU BIOSCIENCES INC·Filed 2022·Granted Oct 18, 2022·2 cites·13 claims
- 0393US11034763B2Flag tagged CD19-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2018·Granted Jun 15, 2021·8 cites·8 claims
- 0493US11021542B1Humanized BCMA antibody and BCMA-CAR-T cellsCARIBOU BIOSCIENCES INC·Filed 2021·Granted Jun 1, 2021·2 cites·20 claims
- 0592US10927182B2Humanized BCMA antibody and BCMA-CAR-T cellsCARIBOU BIOSCIENCES INC·Filed 2020·Granted Feb 23, 2021·2 cites·18 claims
- 0690US11725053B2Chimeric antigen receptors comprising a human transferrin epitope sequencePROMAB BIOTECHNOLOGIES INC·Filed 2020·Granted Aug 15, 2023·2 cites·17 claims
- 0790US11299549B2Humanized BCMA antibody and BCMA-CAR-T cellsCARIBOU BIOSCIENCES INC·Filed 2021·Granted Apr 12, 2022·1 cites·22 claims
- 0889US6528625B1Anti-CCR5 antibodies and kits comprising sameMILLENNIUM PHARM INC·Filed 1997·Granted Mar 4, 2003·100 cites·36 claims
- 0989US6488930B1Anti-CCR4 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 1999·Granted Dec 3, 2002·99 cites·64 claims
- 1089US6245332B1Modulation of systemic memory T cell traffickingUNIV LELAND STANFORD JUNIOR·Filed 1999·Granted Jun 12, 2001·65 cites·15 claims
- 1188US7138117B1Anti-CCR4 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2002·Granted Nov 21, 2006·43 cites·28 claims
- 1287US12227589B2Epcam antibody and Epcam-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2021·Granted Feb 18, 2025·1 cites·10 claims
- 1384US7038018B2Antibodies and ligands for “Bonzo” chemokine receptorMILLENNIUM PHARM INC·Filed 2001·Granted May 2, 2006·22 cites·60 claims
- 1483US12492264B2Anti-ROR1 antibody and ROR1-targeting engineered cellsCARIBOU BIOSCIENCES INC·Filed 2024·Granted Dec 9, 2025·0 cites·9 claims
- 1583US12435152B2Humanized BCMA antibody and BCMA-CAR-T cellsCARIBOU BIOSCIENCES INC·Filed 2022·Granted Oct 7, 2025·0 cites·18 claims
- 1680US12202896B2CAR-T cells with humanized CD19 ScFv with mutation in CDR 1 regionZHEJIANG RUIJIAMEI BIOTECH CO LTD·Filed 2021·Granted Jan 21, 2025·1 cites·11 claims
- 1780US11932703B2Anti-ROR1 antibody and ROR1-targeting engineered cellsCARIBOU BIOSCIENCES INC·Filed 2023·Granted Mar 19, 2024·0 cites·18 claims
- 1875US2025163171A1Humanized bcma antibody and bcma-car-t cellsCARIBOU BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1973US6881406B2Modulation of systemic memory T cell traffickingMILLENNIUM PHARM INC·Filed 2001·Granted Apr 19, 2005·5 cites·14 claims
- 2070US9240039B2Method for fast test strip intensity recognitionCONG GE·Filed 2014·Granted Jan 19, 2016·6 cites·15 claims
- 2167US12448443B2CS1 antibody and anti-CS1-CAR-t cellsPROMAB BIOTECHNOLOGIES INC·Filed 2022·Granted Oct 21, 2025·0 cites·12 claims
- 2266US12173077B2Humanized BCMA antibody and BCMA-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2023·Granted Dec 24, 2024·0 cites·1 claims
- 2365US12103970B2CAR-T cells with humanized CD19 ScFvPROMAB BIOTECHNOLOGIES INC·Filed 2021·Granted Oct 1, 2024·0 cites·14 claims
- 2465US7208152B2Antibodies for “Bonzo” chemokine receptor and therapeutic uses thereofMILLENNIUM PHARM INC·Filed 2002·Granted Apr 24, 2007·1 cites·68 claims
- 2563US11692034B2CD47-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2019·Granted Jul 4, 2023·0 cites·10 claims
- 2663US10086055B2Adherent cancer cell line expressing a hematological tumor antigenPROMAB BIOTECHNOLOGIES INC·Filed 2017·Granted Oct 2, 2018·0 cites·3 claims
- 2761US12059436B2BCMA-CAR-T cellsPROMAB BIOTECHNOLOGIES INC·Filed 2020·Granted Aug 13, 2024·0 cites·9 claims
- 2861US12030957B2PLAP-CAR-effector cellsPROMAB BIOTECHNOLOGIES INC·Filed 2020·Granted Jul 9, 2024·0 cites·7 claims
- 2960US2022348688A1Plap-cd3 epsilon bispecific antibodiesPROMAB BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 3059US2025388695A1Epcam-cd3 epsilon bispecific antibodiesPROMAB BIOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
- 3159US2009137527A1Compositions and methods for modulating immune functionRESOLVYX PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3258US11332513B2Chimeric antigen receptors having GITR intracellular domain as co-stimulatory domainPROMAB BIOTECHNOLOGIES INC·Filed 2019·Granted May 17, 2022·0 cites·7 claims
- 3356US2019015493A1Adherent cancer cell line expressing a hematological tumor antigenPROMAB BIOTECHNOLOGIES INC·Filed 2018·Application pending·0 cites
- 3455US11263483B2Method and apparatus for recognizing image and storage mediumBEIJING DAJIA INTERNET INFORMATION TECH CO LTD·Filed 2020·Granted Mar 1, 2022·0 cites·12 claims
- 3555US2023227557A1Pd-l1-specific antibody and anti-pd-l1-car-t cellsPROMAB BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 3655US2021340271A1Cd37-antibody and cd37-car-t cellsPROMAB BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 3753US2020190163A1Humanized bcma-car-t cellsWU LIJUN·Filed 2019·Application pending·0 cites
- 3853US2005169918A1Modulation of systemic memory T cell traffickingFiled 2005·Application pending·0 cites
- 3951US2007031896A1Anti-CCR4 antibodies and methods of use thereforWU LIJUN·Filed 2006·Application pending·0 cites
- 4050US2025188415A1Nk cells transfected with car rna-lnpPROMAB BIOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
- 4148US2021117726A1Method for training image classifying model, server and storage mediumBEIJING DAJIA INTERNET INFORMATION TECH CO LTD·Filed 2020·Application pending·0 cites
- 4245US2019023764A1Car having replicated binding motifs in a co-stimulatory domainPROMAB BIOTECHNOLOGIES INC·Filed 2018·Application pending·0 cites
- 4335US10033912B2Cassette attachment device for detecting intensity of test strip cassetteEHOME HEALTH INC·Filed 2016·Granted Jul 24, 2018·0 cites·22 claims
- 4435US2019369123A1Acpa-negative ra diagnostic marker and application thereofPeking Union Medical College Hospital·Filed 2017·Application pending·0 cites
- 4535US2020057062A1Diagnostic marker for predicting efficacy of ra drug and application thereofPeking Union Medical College Hospital·Filed 2017·Application pending·0 cites
- 4635US2019361019A1Acpa-negative ra diagnostic marker and application thereofPeking Union Medical College Hospital·Filed 2017·Application pending·0 cites
- 4731US2003166870A1Anti-CCR5 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lijun Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →